Commission-free ETFs available as of June 3, 2019

The best-performing funds were the small- and mid-cap-oriented SPDR S&P Biotech (XBI) and SPDR S&P Pharmaceuticals (XPH). The former gained 12.47 percent and the latter 8.05 percent. The rallies … ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download